FindTrial
Sign In

A randomized clinical trial to compare topical lidocaine-prilocaine cream (Emla) versus 2% lidocaine infiltration to first-degree perineal tears repair

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-512728-12-00
Acronym
DES-26-E(C)A
Enrollment
84
Registered
2024-07-23
Start date
2024-08-12
Completion date
Unknown
Last updated
2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First-dregree perineal laceration

Brief summary

The values ​​of the Visual Analogue Scale (VAS) of pain modified according to how they express women.

Detailed description

Characteristics of the tear: location., Characteristics of childbirth and postpartum: onset of labor, use of alternative therapies to pain management and performing uninterrupted skin-to-skin for the two hours postpartum (except when the newborn is weighed)., Characteristics of the newborn: weight and sex., Characteristics of women: parity and age.

Interventions

DRUGLidocaína B. Braun 20 mg/ml solución inyectable
DRUGEMLA 25 mg/g + 25 mg/g crema

Sponsors

Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
The values ​​of the Visual Analogue Scale (VAS) of pain modified according to how they express women.—

Secondary

MeasureTime frame
Characteristics of the tear: location., Characteristics of childbirth and postpartum: onset of labor, use of alternative therapies to pain management and performing uninterrupted skin-to-skin for the two hours postpartum (except when the newborn is weighed)., Characteristics of the newborn: weight and sex., Characteristics of women: parity and age.—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026